Glenn Gregory M's Form 4 filing
Novavax Inc (NVAX) · filed Oct 1, 2021
- Accession no.
- 0001209191-21-058570
- Filed
- Oct 1, 2021
- Trade date
- Sep 30, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $143.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glenn Gregory MCIK 0001342823 | Officer (President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 | Common Stock | SSaleDisposed | −51 | $202.84 | −$10,344.84 | 4,703 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −55 | $203.94 | −$11,216.7 | 4,648 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −16 | $205.01 | −$3,280.16 | 4,632 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −280 | $207.01 | −$57,962.8 | 4,352 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −117 | $207.99 | −$24,334.83 | 4,235 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −118 | $209.27 | −$24,693.86 | 4,117 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −40 | $210.16 | −$8,406.4 | 4,077 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −16 | $211.39 | −$3,382.24 | 4,061 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.